Comparison
1q24q25 Microdeletion Syndrome Cn252652 vs 11q22 2q22 3 Microdeletion Syndrome C5680062
Clinical comparison between 1q24q25 Microdeletion Syndrome CN252652 and 11q22 2q22 3 Microdeletion Syndrome for differential diagnosis and treatment planning.
1q24q25 Microdeletion Syndrome Cn252652
A genetic condition involving deletion of material from chromosome 1. Leads to developmental delays, growth issues, and various medical concerns. Treatment addresses individual symptoms.
11q22 2q22 3 Microdeletion Syndrome C5680062
A rare genetic condition where a small segment of chromosome 11 is missing. It can affect development and cause various health concerns. Treatment focuses on managing specific symptoms with supportive care.
6 comparison axes
Onset
1q24q25 Microdeletion Syndrome Cn252652
Variable
11q22 2q22 3 Microdeletion Syndrome C5680062
0-null
Onset patterns differ
Severity
1q24q25 Microdeletion Syndrome Cn252652
severe
11q22 2q22 3 Microdeletion Syndrome C5680062
moderate
Different severity levels
Chronic
1q24q25 Microdeletion Syndrome Cn252652
Chronic
11q22 2q22 3 Microdeletion Syndrome C5680062
Chronic
Differing course
Communicable
1q24q25 Microdeletion Syndrome Cn252652
No
11q22 2q22 3 Microdeletion Syndrome C5680062
No
Different transmission
Body System
1q24q25 Microdeletion Syndrome Cn252652
congenital
11q22 2q22 3 Microdeletion Syndrome C5680062
congenital
Same/different system
Category
1q24q25 Microdeletion Syndrome Cn252652
rare-disease
11q22 2q22 3 Microdeletion Syndrome C5680062
genetic
Different category
Bottom line
1q24q25-microdeletion-syndrome-CN252652 and 11q22-2q22-3-microdeletion-syndrome-C5680062 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 1q24q25 Microdeletion Syndrome Cn252652 | 11q22 2q22 3 Microdeletion Syndrome C5680062 | Discriminating power |
|---|---|---|---|
| Developmental delay | Described as a possible feature; severity and domains are not specified. | Development may be affected, but the pattern is not established. | Low |
| Growth concerns | Growth issues are mentioned, without defined measurements. | Growth effects are not established from the supplied description. | Moderate |
| Overall clinical burden | Source severity is labeled severe, with varied medical concerns. | Source severity is labeled moderate, with varied health concerns. | Moderate |
When to favor each condition
Choose 1q24q25 Microdeletion Syndrome Cn252652 when
A deletion involving 1q24-q25 is confirmed
The chromosomal interval, not symptoms alone, identifies this condition.
High
Growth issues accompany developmental delay
This combination is mentioned for the left condition, but is not diagnostic.
Low
A severe congenital presentation needs syndrome-specific counseling
The supplied severity label is severe, pending clinician review.
Moderate
Choose 11q22 2q22 3 Microdeletion Syndrome C5680062 when
A deletion involving 11q22.2-q22.3 is confirmed
The chromosome 11 interval distinguishes it from a chromosome 1 deletion.
High
Developmental concerns occur without a defined growth phenotype
The supplied description emphasizes development but does not establish growth findings.
Low
Counseling uses the supplied moderate-severity label
Severity differs in the source data, but individual outcomes vary.
Moderate
How key tests differ
| Test | 1q24q25 Microdeletion Syndrome Cn252652 | 11q22 2q22 3 Microdeletion Syndrome C5680062 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May detect copy-number loss at 1q24-q25. | May detect copy-number loss at 11q22.2-q22.3. | The genomic coordinates distinguish the conditions; clinician review is required. |
| Karyotype | May miss a small chromosome 1 deletion. | May miss a small chromosome 11 deletion. | A normal karyotype does not exclude either microdeletion. |
| Targeted FISH or locus testing | Informative only if probes cover 1q24-q25. | Informative only if probes cover 11q22.2-q22.3. | A negative targeted test cannot exclude a deletion outside its coverage. |
Prognosis comparison
1q24q25 Microdeletion Syndrome Cn252652
- Outcome
- Long-term outcome is not established; the source labels severity as severe.
- Factors
- Deleted interval, associated anomalies, growth, and developmental needs may influence course.
11q22 2q22 3 Microdeletion Syndrome C5680062
- Outcome
- Long-term outcome is not established; the source labels severity as moderate.
- Factors
- Exact interval, developmental impact, and associated health concerns may influence course.
Time frame: Both are described as chronic congenital conditions; onset details are incomplete.
No mortality or universal outcome can be inferred from the supplied data.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental complications | Delays are described, but specific complications are not established. Developmental effects are possible, without a defined complication profile. Supportive assessment should be individualized. |
| Growth-related concerns | Growth issues are mentioned without thresholds or causes. Not established from the supplied source. Do not infer a diagnosis from growth measurements alone. |
| Associated medical concerns | Various concerns are possible; organ involvement is unspecified. Various health concerns are possible; details are unspecified. Surveillance should follow clinical findings and genetics advice. |
Patient education highlights
- HighGenetic confirmation
The chromosome and deleted interval must be confirmed; similar symptoms do not establish either syndrome.
- HighSupportive care
Care addresses the person's specific developmental, growth, and medical needs rather than using a single treatment.
- MediumUncertainty
Available descriptions are sparse, so prognosis and complication risks require clinician interpretation.